Expression of RPLP1 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPLP1 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 2369.93

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

1887.1

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	4259.2
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	3796.8
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	3610.6
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	3368.6
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	3281.4
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	3072.0
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	2884.3
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	2867.8
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	2812.7
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	2798.8
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	2777.2
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	2767.2
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	2756.4
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	2694.8
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	2660.5
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	2643.0
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	2625.3
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	2618.0
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	2606.7
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	2570.7
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	2566.3
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	2558.8
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	2547.3
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	2479.7
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	2465.6
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	2460.2
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	2431.5
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	2384.8
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	2381.0
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	2369.9
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	2362.0
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	2256.6
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	2234.2
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	2226.1
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	2204.8
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	2194.1
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	2180.6
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	2156.6
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	2123.9
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	2116.4
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	2092.9
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	2092.8
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	2090.8
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	2088.6
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	2073.9
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	2059.4
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	2057.1
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	2050.5
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	2030.3
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	2008.4
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	1992.5
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	1962.8
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	1959.8
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	1950.6
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1950.4
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	1937.9
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	1929.5
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	1927.7
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	1920.0
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	1892.2
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	1870.6
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	1868.9
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	1868.8
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	1864.3
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	1861.2
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	1855.5
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	1843.0
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	1841.9
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	1831.4
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	1822.5
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	1813.0
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	1796.4
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1791.5
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	1783.9
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	1762.6
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1744.0
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1723.8
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1721.0
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	1720.7
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	1711.0
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1708.1
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	1692.2
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	1691.6
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1675.8
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	1673.5
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1654.8
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	1652.9
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	1650.7
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	1649.4
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	1628.8
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	1626.0
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1624.5
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	1622.1
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	1605.0
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	1603.7
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	1594.9
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	1589.4
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1580.4
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	1576.6
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	1563.1
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	1539.3
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	1502.2
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	1483.4
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	1479.7
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1461.0
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	1444.2
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1427.6
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	1425.3
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1423.4
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	1391.9
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	1374.5
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1373.9
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	1373.4
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	1373.0
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	1353.1
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1348.7
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	1333.0
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	1286.8
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	1277.2
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	1259.5
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1237.0
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	1232.3
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1232.0
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	1221.4
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1216.7
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1208.7
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	1208.0
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	1205.2
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	1169.9
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	1111.9
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	1109.9
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1077.9
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	1074.5
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	1066.0
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	1017.2
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	1014.4
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	1009.4
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	997.1
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	983.8
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	977.0
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	782.9
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPLP1 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 82.79

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

113.7

Number of samples

Samples

Sample	Description	pTPM
AK043	N, NA, stage:NA, alive, 660 days	341.1
AK133	N, NA, stage:NA, dead, 360 days	266.8
AK035	N, NA, stage:NA, dead, 210 days	222.1
AK134	N, NA, stage:NA, dead, 360 days	209.8
AK002	N, NA, stage:NA, dead, 570 days	209.4
AK006	N, NA, stage:NA, dead, 360 days	194.5
AK079	N, NA, stage:NA, dead, 210 days	193.6
AK117	N, NA, stage:NA, dead, 210 days	181.5
AK088	N, NA, stage:NA, dead, 360 days	169.5
AK005	N, NA, stage:NA, dead, 240 days	161.6
AK123	N, NA, stage:NA, dead, 180 days	152.7
AK091	N, NA, stage:NA, dead, 210 days	149.0
AK236	N, NA, stage:NA, dead, 360 days	148.0
AK068	N, NA, stage:NA, alive, 360 days	137.9
AK218	N, NA, stage:NA, dead, 180 days	137.2
AK055	N, NA, stage:NA, dead, 240 days	135.4
AK227	N, NA, stage:NA, alive, 300 days	131.5
AK226	N, NA, stage:NA, dead, 360 days	131.1
AK195	N, NA, stage:NA, dead, 390 days	127.5
AK089	N, NA, stage:NA, dead, 330 days	127.0
AK066	N, NA, stage:NA, alive, 960 days	118.9
AK102	N, NA, stage:NA, alive, 1740 days	118.3
AK072	N, NA, stage:NA, dead, 150 days	110.9
AK153	N, NA, stage:NA, dead, 240 days	110.8
AK149	N, NA, stage:NA, dead, 420 days	109.8
AK158	N, NA, stage:NA, dead, 360 days	104.2
AK165	N, NA, stage:NA, alive, 360 days	102.0
AK188	N, NA, stage:NA, alive, 420 days	98.6
AK139	N, NA, stage:NA, dead, 270 days	96.0
AK098	N, NA, stage:NA, dead, 660 days	94.9
AK099	N, NA, stage:NA, dead, 420 days	94.6
AK185	N, NA, stage:NA, alive, 330 days	94.3
AK213	N, NA, stage:NA, alive, 2010 days	92.9
AK074	N, NA, stage:NA, alive, 300 days	92.1
AK081	N, NA, stage:NA, dead, 180 days	92.0
AK071	N, NA, stage:NA, dead, 540 days	91.9
AK167	N, NA, stage:NA, dead, 180 days	90.7
AK178	N, NA, stage:NA, dead, 240 days	89.2
AK030	N, NA, stage:NA, dead, 120 days	87.7
AK053	N, NA, stage:NA, dead, 300 days	83.0
AK205	N, NA, stage:NA, dead, 120 days	82.9
AK041	N, NA, stage:NA, alive, 810 days	82.7
AK216	N, NA, stage:NA, dead, 360 days	80.9
AK124	N, NA, stage:NA, alive, 1920 days	76.0
AK100	N, NA, stage:NA, alive, 960 days	75.0
AK142	N, NA, stage:NA, alive, 90 days	68.2
AK085	N, NA, stage:NA, alive, 660 days	66.9
AK183	N, NA, stage:NA, alive, 360 days	65.2
AK051	N, NA, stage:NA, dead, 360 days	63.2
AK199	N, NA, stage:NA, alive, 1860 days	62.0
AK076	N, NA, stage:NA, alive, 660 days	62.0
AK015	N, NA, stage:NA, alive, 720 days	56.4
AK103	N, NA, stage:NA, alive, 1320 days	54.7
AK231	N, NA, stage:NA, dead, 240 days	52.7
AK049	N, NA, stage:NA, dead, 180 days	45.5
AK173	N, NA, stage:NA, dead, 180 days	45.3
AK003	N, NA, stage:NA, dead, 600 days	39.1
AK156	N, NA, stage:NA, dead, 330 days	20.7
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0217000004	Tumor	1.8
CPT0206230003	Tumor	1.8
CPT0087570003	Tumor	1.1
CPT0189460003	Tumor	1.1
CPT0162020003	Tumor	1.1
CPT0189650004	Tumor	1.0
CPT0162100003	Tumor	0.9
CPT0206110003	Tumor	0.9
CPT0125570003	Tumor	0.9
CPT0219080004	Tumor	0.9
CPT0205570003	Tumor	0.8
CPT0093360003	Tumor	0.8
CPT0205450004	Tumor	0.8
CPT0168380003	Tumor	0.8
CPT0087730003	Tumor	0.6
CPT0087950003	Tumor	0.6
CPT0206560003	Tumor	0.6
CPT0221180003	Tumor	0.5
CPT0206880003	Tumor	0.5
CPT0186100003	Tumor	0.4
CPT0089150003	Tumor	0.4
CPT0218770003	Tumor	0.4
CPT0127480003	Tumor	0.4
CPT0175060003	Tumor	0.3
CPT0189850004	Tumor	0.3
CPT0123530003	Tumor	0.3
CPT0218690004	Tumor	0.3
CPT0168830003	Tumor	0.3
CPT0206780003	Tumor	0.3
CPT0196850003	Tumor	0.3
CPT0205780003	Tumor	0.2
CPT0125220003	Tumor	0.2
CPT0078580003	Tumor	0.2
CPT0127420003	Tumor	0.2
CPT0002410011	Tumor	0.2
CPT0218890004	Tumor	0.2
CPT0217060003	Tumor	0.2
CPT0167640003	Tumor	0.1
CPT0064650003	Tumor	0.1
CPT0167530003	Tumor	0.1
CPT0182500003	Tumor	0.1
CPT0079790003	Tumor	0.1
CPT0224540004	Tumor	0.1
CPT0190360004	Tumor	0.1
CPT0093550003	Tumor	0.1
CPT0217430008	Tumor	0.1
CPT0206450003	Tumor	0.1
CPT0216920008	Tumor	0.1
CPT0064890003	Tumor	0.0
CPT0071100003	Tumor	0.0
CPT0204380003	Normal	0.0
CPT0167970003	Tumor	0.0
CPT0217880003	Tumor	-0.1
CPT0206000004	Tumor	-0.1
CPT0204330003	Normal	-0.1
CPT0217190003	Tumor	-0.1
CPT0168590003	Tumor	-0.1
CPT0182580003	Tumor	-0.1
CPT0217710008	Tumor	-0.1
CPT0228220003	Tumor	-0.1
CPT0224390004	Tumor	-0.2
CPT0204410003	Normal	-0.2
CPT0208980003	Tumor	-0.3
CPT0182550003	Tumor	-0.3
CPT0093450003	Tumor	-0.3
CPT0189750004	Tumor	-0.3
CPT0092440003	Tumor	-0.3
CPT0204340003	Normal	-0.3
CPT0087680003	Tumor	-0.3
CPT0168080003	Tumor	-0.3
CPT0204350003	Normal	-0.3
CPT0207090003	Tumor	-0.3
CPT0168480003	Tumor	-0.4
CPT0093510003	Tumor	-0.4
CPT0201710003	Tumor	-0.4
CPT0218670003	Tumor	-0.4
CPT0161730003	Tumor	-0.4
CPT0093590003	Tumor	-0.4
CPT0204420003	Normal	-0.4
CPT0225760003	Tumor	-0.4
CPT0218330004	Tumor	-0.4
CPT0204400003	Normal	-0.5
CPT0189570004	Tumor	-0.5
CPT0205670004	Tumor	-0.5
CPT0189250003	Tumor	-0.5
CPT0218830004	Tumor	-0.5
CPT0167860004	Tumor	-0.5
CPT0217100003	Tumor	-0.5
CPT0204390003	Normal	-0.5
CPT0209440003	Tumor	-0.5
CPT0171580008	Tumor	-0.5
CPT0225730003	Tumor	-0.5
CPT0168720003	Tumor	-0.5
CPT0205890003	Tumor	-0.5
CPT0224600003	Tumor	-0.6
CPT0125510003	Tumor	-0.6
CPT0207030003	Tumor	-0.6
CPT0104330003	Tumor	-0.6
CPT0218960004	Tumor	-0.6
CPT0168270003	Tumor	-0.6
CPT0162140003	Tumor	-0.6
CPT0206330003	Tumor	-0.7
CPT0204360003	Normal	-0.7
CPT0204370003	Normal	-0.7
CPT0167750004	Tumor	-0.7
CPT0199770003	Tumor	-0.8
CPT0224330003	Tumor	-0.8
CPT0206670004	Tumor	-0.9
CPT0104220003	Tumor	-1.1
CPT0190240004	Tumor	-1.4
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis